Harvard Medicine home webweekly
Feb. 21, 2005

In Print


Steven Gygi (left) and Bryan Ballif
Photo by Steve Gilbert

From Focus:
Functional Protein Changes Caught and Quantified
Just knowing that a protein is expressed in a cell does not reveal what that molecule is up to; chemical modifications like phosphorylation—the addition of a phosphate group—can radically change protein function. Research by Steven Gygi (left), Bryan Ballif, and colleagues uses powerful mass spectrometry to pinpoint how protein phosphorylation changes over time. Among other findings, the study yields new information about a protein implicated in cancer.

Upcoming

Ethics Forum:
Abu Ghraib and Guantanamo: Medical Professionalism, Dual Loyalty, and Human Rights
Robert Jay Lifton, Steven Miles, Leonard Rubenstein, and Mildred Solomon
HMS
Tuesday, March 1
4:00–6:00 p.m.

Lab Works

A multimedia site featuring Harvard Medical research.


StudenTalk

Personal takes on issues inside and outside the classroom.

 

Spotlight


Countway Library logo

Name of Countway’s Rare Books Department Is History
Countway Librarys Rare Books and Special Collections Department is changing its name to the Center for the History of Medicine, effective April 1. The center aims to promote the study of the history of medicine, encouraging a better understanding of the complex interaction between medicine and society.


Student Scene

Erica Seiguer
Photo by Graham Ramsay

Lines Drawn Over Recommended Cuts in Medicare Hospital Reimbursement
In January, the Medicare Payment Advisory Commission (MedPAC) proposed that reimbursement for hospital care be decreased. Many hospital executives and even some members of MedPAC say that if the cuts go into effect, hospital care may be threatened.

Headlines

News from HMS and Its Affiliates

Study Shows Naturally Occurring Proteins Protect Against Rapid Cancer Growth (select "In Research")

Long-term Celebrex Use Increases Cardiovascular Event Risk

Mechanical Tension Helps Shape Lung Development

A More Accurate Screening Test for Prostate Cancer?

Study Finds New Designer Drug Is Potent Treatment for Chronic Myelogenous Leukemia

Back Issues

Online Publications

Calendar

HMS Home

InteliHealth

Feedback